Fibroblast growth factor 21 (FGF21) is a member of the. Distinct Changes in Serum Fibroblast Growth Factor 21 Levels in Different Subtypes of Diabetes
|
|
- Thomasine Bonnie Barton
- 6 years ago
- Views:
Transcription
1 JCEM ONLINE Brief Report Endocrine Research Distinct Changes in Serum Fibroblast Growth Factor 21 Levels in Different Subtypes of Diabetes Yang Xiao, Aimin Xu, Lawrence S. C. Law, Cheng Chen, Hui Li, Xia Li, Lin Yang, Shiping Liu, Zhiguang Zhou, and Karen S. L. Lam Diabetes Center (Y.X., H.L., X.L., L.Y., S.L., Z.Z.), Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Key Laboratory of Diabetes Immunology, Ministry of Education, Central South University, Changsha, Hunan , China; Departments of Medicine (A.X., L.S.C.L., C.C., K.S.L.L.) and Pharmacology and Pharmacy (A.X.) and Research Center of Heart, Brain, Hormone, and Healthy Aging (Y.X., A.X., K.S.L.L.), University of Hong Kong, Hong Kong Aims: Fibroblast growth factor (FGF) 21 is an endocrine factor with multiple beneficial effects on glucose and lipid metabolism in animals. This study aimed to investigate the association of serum FGF21 levels with type 1 diabetes, latent autoimmune diabetes in adults (LADA) and type 2 diabetes. Methods: Serum FGF21 levels were determined by ELISA in patients with type 1 diabetes (n 76), LADA (n 68), type 2 diabetes (n 77), and their age- and sex-matched controls. The association of serum FGF21 with markers of autoimmunity was studied. Results: In type 1 diabetic patients, serum FGF21 levels were significantly lower than controls [108.3 ( ) vs ( ) pg/ml, P 0.001]. In LADA patients, serum FGF21 levels were significantly lower than controls after adjustment for body mass index [210.9 ( ) vs ( ) pg/ml, P 0.003]. By contrast, serum FGF21 levels in type 2 diabetic patients were significantly higher than controls [381.2 ( ) vs ( ) pg/ml, P 0.006]. FGF21 levels increased progressively from type 1 diabetes, LADA, to type 2 diabetes (P for global trend). Furthermore, FGF21 levels correlated inversely with titers of glutamic acid decarboxylase and insulinoma-associated protein 2 autoantibodies in type 1 diabetic and LADA patients. Conclusions: Serum FGF21 level is increased in type 2 diabetes but decreased in type 1 diabetes and LADA. In autoimmune diabetes, the reduction in circulating FGF21 is closely associated with markers of pancreatic -cell autoimmunity. (J Clin Endocrinol Metab 97: E54 E58, 2012) Fibroblast growth factor 21 (FGF21) is a member of the endocrine FGF subfamily and a major metabolic regulator (1). Despite the multiple salutatory effects of FGF21 on glucose and lipid metabolism in animals, circulating FGF21 levels are elevated in obesity (2) and patients with type 2 diabetes mellitus (3, 4), dyslipidemia (2, 5), impaired glucose tolerance (3), nonalcoholic fatty liver disease (6), and coronary heart disease (7). It has been proposed that the elevated level of FGF21 (hyper-fgf21-nemia) in obesity-related disorders is attributed to FGF21 resistance, a phenomenon reminiscent of hyperinsulinemia and insulin resistance (8). Although several previous studies have reported the elevated levels of FGF21 in type 2 diabetic patients (2 4), the ISSN Print X ISSN Online Printed in U.S.A. Copyright 2012 by The Endocrine Society doi: /jc Received July 2, Accepted September 22, First Published Online October 19, 2011 relationship of FGF21 with autoimmune diabetes remains unclear. In this study, we investigated the changes in serum FGF21 levels in patients with type 1 diabetes, latent autoimmune diabetes in adults (LADA), and type 2 diabetes, in comparison with their respective age- and sex-matched controls. In addition, we analyzed the association of serum FGF21 levels with markers of autoimmunity in our patients. Participants and Methods Participants Three groups of Chinese diabetic patients, within 1 yr of their disease diagnosis, and their respective age and sex-matched con- Abbreviations: BMI, Body mass index; FGF21, fibroblast growth factor 21; GADA, glutamic acid decarboxylase autoantibody; IA2A, insulinoma-associated protein 2 autoantibody; LADA, latent autoimmune diabetes in adults. E54 jcem.endojournals.org J Clin Endocrinol Metab, January 2012, 97(1):E54 E58
2 J Clin Endocrinol Metab, January 2012, 97(1):E54 E58 jcem.endojournals.org E55 trols were recruited. Diabetes was diagnosed according to American Diabetes Association criteria (9). Newly diagnosed type 1 diabetic patients (n 76) were recruited at the Diabetes Center of the Second Xiangya Hospital, Central South University. Type 2 diabetic patients (n 77) were enrolled from an ongoing clinical project (inclusion criteria shown in supplementary data). LADA patients (n 68) were selected from the LADA China Studies using the following inclusion criteria (10): 1) age at onset more than 30 yr; 2) glutamic acid decarboxylase autoantibody (GADA) positive; and 3) no ketosis within the first 6 months after diagnosis. Age- and, sex-matched controls for the type 1 diabetic group (n 77) were recruited from children in the community who came for health screening at the Children Health Center of the Second Xiangya Hospital, Central South University. Controls for LADA (n 69) and type 2 diabetes mellitus (n 75) were recruited from the China National Diabetes and Metabolic Disorders Study (inclusion criteria for controls shown in Supplementary Data, published on The Endocrine Society s Journals Online web site at The study protocol was approved by the Institutional Review Board of Second Xiangya Hospital, Central South University. All study subjects provided written informed consent. Clinical and biochemical assessments After overnight fasting, a venous blood specimen was collected in the morning (around 0800 h) for analysis of various biochemical parameters (as shown in Supplementary Data). Serum FGF21 was measured using an ELISA kit established in our laboratory (Antibody and Immunoassay Services, the University of Hong Kong) (11). The titers of GADA and insulinoma-associated protein 2 autoantibody (IA2A) were determined using an in-house radioligand assay as previously described (12, 13). The cutoff titers of positivity for GADA and IA2A were 0.05 and 0.02, which were determined according to the 99th percentile of 188 and 171 healthy controls, respectively (14). The sensitivity and the specificity were 72 and 98% for GADA assay and were 66 and 99% for the IA2A assay, respectively. Statistical analysis All statistical analyses were performed with the Statistical Package for Social Science version 16.0 (SPSS, Inc., Chicago, IL). Data were expressed as mean SD or median with interquartile range as appropriate. Data that were not normally distributed, as determined using the Kolmogorov-Smirnov test, were logarithmically transformed before analysis. Correlations between FGF21 and biochemical variables were analyzed with Pearson correlation or partial correlation as appropriate. Data comparisons between the groups were performed using 2 tests for categorical variables and an unpaired t test or a univariate general linear model as indicated for continuous variables. Comparisons among groups were performed using one-way ANOVA or the univariate general linear model. P 0.05 was considered statistically significant. Results Serum FGF21 levels in different types of diabetes Characteristics of patients with type 1 diabetes mellitus (n 76), LADA (n 68), and type 2 diabetes mellitus (n 77), and their respective age- and sex-matched controls are described in Table 1. Among 76 type 1 diabetic patients, 60 were on insulin treatment. The disease duration was 16 (7 306]) (median and interquartile range) days. Compared with healthy controls, patients with type 1 diabetes mellitus had higher fasting glucose and lower body mass index (BMI), blood pressure, and fasting C-peptide levels. They also had significantly lower serum FGF21 levels compared with controls [108.3 ( ) vs ( ) pg/ml, P 0.001, Table 1]. After adjustment for BMI, serum FGF21 was still significantly lower in type 1 diabetic patients (P 0.004, Supplemental Fig. TABLE 1. controls Clinical and metabolic parameters of different groups of diabetic patients vs. age- and sex-matched T1DM LADA T2DM Parameters Cases Controls Cases Controls Cases Controls n Age (yr) Sex (men/women) 28/48 36/41 42/26 35/34 42/35 41/34 BMI (kg/m 2 ) a b b Waist circumference (cm) Men b b Women b b Systolic blood pressure (mm Hg) b b b Diastolic blood pressure (mm Hg) a b c Fasting glucose (mmol/liter) b b b Fasting C-peptide (pmol/liter) d 70.1 ( ) b ( ) ( ) c ( ) ( ) b ( ) LDL cholesterol (mmol/liter) b b HDL cholesterol (mmol/liter) b Triglycerides (mmol/liter) d 0.8 ( ) 0.8 ( ) 1.6 ( ) b 0.8 ( ) 1.5 ( ) b 0.8 ( ) FGF21 (pg/ml) d ( ) b ( ) ( ) ( ) ( ) c ( ) T1DM, Type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus; HDL, high-density lipoprotein; LDL, low-density lipoprotein. a Compared with control, P b Compared with control, P c Compared with control, P d Natural logarithm transformed before analysis.
3 E56 Xiao et al. FGF21 and Autoimmune Diabetes J Clin Endocrinol Metab, January 2012, 97(1):E54 E58 1A). In subjects with type 1 diabetes, hemoglobin A1c was %, indicating poor metabolic control. In addition, total serum protein levels were significantly lower in subjects with type 1 diabetes ( vs g/liter in controls, P 0.001). Nevertheless, serum FGF21 remained significantly decreased in type 1 diabetic patients after adjusting for total protein levels (P 0.01). Among 68 LADA patients, 16 were on insulin treatment, 27 were on oral antidiabetic drugs, and six were on insulin and oral antidiabetic drugs. The disease duration was 48 (10 237) days. Compared with controls, patients with LADA had higher fasting glucose, BMI, waist circumference, blood pressure, triglycerides, and low-density lipoprotein cholesterol but lower fasting C-peptide. There was a moderate but not significant decrease in serum FGF21 in LADA patients compared with controls [210.9 ( ) vs ( ) pg/ml, P 0.274, Table 1]. After adjustment for BMI, serum FGF21 was significantly lower in LADA patients (P 0.003, Supplemental Fig. 1A). Among 77 type 2 diabetic patients, 46 were on oral antidiabetic drugs, three were on insulin treatment, and three were on insulin and oral antidiabetic drugs. The disease duration was 64 ( ) days. Compared with controls, patients with type 2 diabetes mellitus had higher fasting glucose, BMI, waist circumference, blood pressure, triglycerides, low-density lipoprotein cholesterol, and C-peptide. Serum FGF21 levels were significantly increased in type 2 diabetic patients compared with controls [381.2 ( ) vs ( ) pg/ml, P 0.006, Table 1], and such a significance remained, even after adjustment for BMI (P 0.045, Supplemental Fig. 1A). FGF21 levels were increased from type 1 diabetes mellitus, LADA to type 2 diabetes mellitus (Supplemental Fig. 1B, P for global trend). After adjustment for age and BMI, the increasing trend remained significant (P 0.039). In 34 type 1 diabetic patients, 28 LADA patients, and 76 type 2 diabetic patients who had available data on serum creatinine (type 1: ; LADA: ; type 2: mol/liter). FGF21 levels still increased progressively from type 1 diabetes, LADA to type 2 diabetes (P for global trend) after adjustment for age, BMI, and estimated glomerular filtration rate. Relationship of serum FGF21 with markers of autoimmunity In type 1 diabetic and LADA patients, FGF21 level correlated inversely with GADA and IA2A autoantibody titer (r 0.215, P 0.011; r 0.429, P 0.001, respectively, Fig. 1). FIG. 1. Correlations between serum FGF21 and titers of GADA (n 138) (A) or IA2A (n 101) (B) in type 1 diabetic and LADA patients. Ln, Natural logarithm. Discussion Although the function of FGF21 as a metabolic regulator has been extensively characterized in animals using both gain-of-functional and loss-of-functional approaches, its relevance to metabolic disorders in human remains poorly characterized. The present study provides the first evidence showing distinct changes in serum FGF21 levels in different subtypes of diabetes. Serum FGF21 levels are significantly increased in type 2 diabetic patients, modestly reduced in LADA patients, but markedly decreased in type 1 diabetic patients. Furthermore, our study is the first to demonstrate, in patients with type 1 diabetes or LADA, the link between serum FGF21 levels and circulating autoantibodies directed against the pancreatic -cell. The elevation in circulating FGF21 levels in type 2 diabetic patients may be attributed to a compensatory response, secondary to FGF21 resistance, which has been previously reported (3, 11). The decreased circulating FGF21 levels in type 1 diabetes and LADA may reflect the impaired -cell function in these two subtypes of autoimmune diabetes. This con-
4 J Clin Endocrinol Metab, January 2012, 97(1):E54 E58 jcem.endojournals.org E57 clusion was supported by our findings that circulating FGF21 was associated positively with fasting C-peptide (Supplemental Fig. 2) and negatively with titers of autoimmune antibodies related to -cell destruction. Notably, animal studies have demonstrated that FGF21 is highly expressed in the pancreas (15) and may act in an autocrine manner to protect the mass and function of pancreatic -cells (16). Rat Islets and INS-1E cells treated with FGF21 are partially protected from glucolipotoxicity and cytokine-induced apoptosis. In islets isolated from diabetic mice, FGF21 treatment increases islet insulin content and potentiates glucose-induced insulin secretion (16). In addition, FGF21 is expressed in pancreatic acinar cells, and its expression is markedly elevated during ceruleininduced pancreatitis (17). Both gain-of-function and lossof-function studies in mice showed that cerulein-induced pancreatitis-induced elevation of FGF21 expression in acinar cells represented a protective response to prevent pancreatic acini from overt damage. Taken together, these findings suggest that decreased circulating levels of FGF21 in autoimmune diabetes could be attributed in part to the reduced FGF21 production in pancreas, which in turn further aggravates islet -cell destruction. Nevertheless, whether the pancreatic islet is a potential source of circulating FGF21 and how islet-derived FGF21 is regulated remain to be investigated. Conflicting data have been reported with respect to the effect of insulin on FGF21 expression in humans (18 20). Two studies demonstrated that insulin stimulated FGF21 expression during hyperinsulinemic clamp (18, 19), whereas another study observed a significant increase in FGF21 during hypoinsulinemia (20). In our study, type 1 diabetic patients and some of the LADA patients had already received insulin replacement therapy, and fasting insulin level in these patients was similar to that of type 2 diabetic patients, suggesting that decreased circulating FGF21 in our patients with autoimmune diabetes was not due to low serum insulin levels. However, we cannot exclude the possibility that endogenous insulin has greater effects on FGF21 levels than exogenously administered insulin because circulating FGF21 levels correlated with fasting C-peptide (Supplemental Fig. 2), a marker of endogenous insulin secretion. Another notable observation of the present study is that the magnitude of decrease in circulating FGF21 in LADA patients is much smaller than in type 1 diabetic patients. This phenomenon may be due to the fact that LADA is only a mild form of autoimmune diabetes with a slow progression to pancreatic islet destruction and the levels of C-peptide are not as low as those in type 1 diabetic patients (Table 1). In addition, LADA patients share some common clinical features with type 2 diabetes, such as components of the metabolic syndrome and insulin resistance, which may cause a compensatory up-regulation of FGF21 in the liver. In summary, the findings from this study demonstrate that circulating FGF21 levels may be explored as a potential biomarker to discriminate different subtypes of diabetes. In patients with autoimmune diabetes, serum FGF21 level is associated positively with circulating C-peptide levels but negatively with the markers of -cell directed autoimmunity. The precise mechanism that leads to decreased FGF21 production in autoimmune diabetes remains to be further investigated. Acknowledgments Authors Y.X. and A.X. interpreted the data and drafted and revised the article. L.S.C.L. and C.C. analyzed and interpreted the data and revised the article. H.L., X.L., L.Y., and S.P.L. collected and interpreted the data. Z.G.Z. and K.S.L.L. supervised the studies, contributed to the discussion, and revised/edited the article. All of the authors approved the final version of the article. Address all correspondence and requests for reprints to: Karen S. L. Lam, Department of Medicine and Research Center of Heart, Brain, Hormone, and Healthy Aging, the University of Hong Kong, Hong Kong. ksllam@hku.hk; or Zhiguang Zhou, Diabetes Center, Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Key Laboratory of Diabetes Immunology, Ministry of Education, Central South University, Changsha, Hunan, China. zhouzg@hotmail.com. This work was supported by Collaborative Research Fund (Grant HKU3/09C) from the Research Grant Council of Hong Kong (to K.S.L.L.), Seeding Fund for Basic Research and a matching fund for National 973 projects from the University of Hong Kong (to A.X.), Key Laboratory of Diabetes International Cooperation and Exchange of the National Natural Science Foundation of China (Grant No ), the National Key Technology Research and Development Program for the 11th 5-yr plan (Grant 2006BA102B08), and the European Foundation for the Study of Diabetes (Grant EFSD/CDS/Lilly-2010) (to Z.Z.). Disclosure Summary: The authors declare that there is no duality of interest associated with this manuscript. References 1. Itoh N, Ornitz DM 2011 Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease. J Biochem 149: Zhang X, Yeung DC, Karpisek M, Stejskal D, Zhou ZG, Liu F, Wong RL, Chow WS, Tso AW, Lam KS, Xu A 2008 Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 57: Chavez AO, Molina-Carrion M, Abdul-Ghani MA, Folli F, Defronzo RA, Tripathy D 2009 Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes
5 E58 Xiao et al. FGF21 and Autoimmune Diabetes J Clin Endocrinol Metab, January 2012, 97(1):E54 E58 and correlates with muscle and hepatic insulin resistance. Diabetes Care 32: Mraz M, Bartlova M, Lacinova Z, Michalsky D, Kasalicky M, Haluzikova D, Matoulek M, Dostalova I, Humenanska V, Haluzik M 2009 Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity. Clin Endocrinol (Oxf) 71: Li H, Bao Y, Xu A, Pan X, Lu J, Wu H, Lu H, Xiang K, Jia W 2009 Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects. J Clin Endocrinol Metab 94: Li H, Fang Q, Gao F, Fan J, Zhou J, Wang X, Zhang H, Pan X, Bao Y, Xiang K, Xu A, Jia W 2010 Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride. J Hepatol 53: Lin Z, Wu Z, Yin X, Liu Y, Yan X, Lin S, Xiao J, Wang X, Feng W, Li X 2010 Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile. PLoS One 5:e Fisher FM, Chui PC, Antonellis PJ, Bina HA, Kharitonenkov A, Flier JS, Maratos-Flier E 2010 Obesity is a fibroblast growth factor 21 (FGF21)-resistant state. Diabetes 59: Diagnosis and classification of diabetes mellitus. Diabetes Care 30(Suppl 1):S42 S Fourlanos S, Dotta F, Greenbaum CJ, Palmer JP, Rolandsson O, Colman PG, Harrison LC 2005 Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia 48: Chen C, Cheung BM, Tso AW, Wang Y, Law LS, Ong KL, Wat NM, Xu A, Lam KS 2011 High Plasma Level of Fibroblast Growth Factor 21 Is an Independent Predictor of Type 2 Diabetes: A 5.4-year population-based prospective study in Chinese subjects. Diabetes Care 34: Petersen JS, Hejnaes KR, Moody A, Karlsen AE, Marshall MO, Høier-Madsen M, Boel E, Michelsen BK, Dyrberg T 1994 Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 43: Savola K, Bonifacio E, Sabbah E, Kulmala P, Vähäsalo P, Karjalainen J, Tuomilehto-Wolf E, Meriläinen J, Akerblom HK, Knip M 1998 IA-2 antibodies a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood Diabetes in Finland Study Group. Diabetologia 41: Yang L, Luo S, Huang G, Peng J, Li X, Yan X, Lin J, Wenzlau JM, Davidson HW, Hutton JC, Zhou Z 2010 The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese. Diabetes Metab Res Rev 26: Fon Tacer K, Bookout AL, Ding X, Kurosu H, John GB, Wang L, Goetz R, Mohammadi M, Kuro-o M, Mangelsdorf DJ, Kliewer SA 2010 Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse. Mol Endocrinol 24: Wente W, Efanov AM, Brenner M, Kharitonenkov A, Köster A, Sandusky GE, Sewing S, Treinies I, Zitzer H, Gromada J 2006 Fibroblast growth factor-21 improves pancreatic -cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways. Diabetes 55: Johnson CL, Weston JY, Chadi SA, Fazio EN, Huff MW, Kharitonenkov A, Köester A, Pin CL 2009 Fibroblast growth factor 21 reduces the severity of cerulein-induced pancreatitis in mice. Gastroenterology 137: Mai K, Andres J, Biedasek K, Weicht J, Bobbert T, Sabath M, Meinus S, Reinecke F, Möhlig M, Weickert MO, Clemenz M, Pfeiffer AF, Kintscher U, Spuler S, Spranger J 2009 Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth factor-21. Diabetes 58: Hojman P, Pedersen M, Nielsen AR, Krogh-Madsen R, Yfanti C, Akerstrom T, Nielsen S, Pedersen BK 2009 Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia. Diabetes 58: Mai K, Schwarz F, Bobbert T, Andres J, Assmann A, Pfeiffer AF, Spranger J 2011 Relation between fibroblast growth factor-21, adiposity, metabolism, and weight reduction. Metabolism 60:
Fibroblast Growth Factor-21 Is Induced in Human Skeletal Muscles by Hyperinsulinemia
BRIEF REPORT Fibroblast Growth Factor-21 Is Induced in Human Skeletal Muscles by Hyperinsulinemia Pernille Hojman, Maria Pedersen, Anders Rinnov Nielsen, Rikke Krogh-Madsen, Christina Yfanti, Thorbjørn
More informationCorrelation of fibroblast growth factor 21 serum levels with metabolic parameters in Japanese subjects
28 ORIGINAL Correlation of fibroblast growth factor 21 serum levels with metabolic parameters in Japanese subjects Qing-Ri Jin 1, Yukiko Bando 2, Katsuyuki Miyawaki 1, Yosuke Shikama 2, Chisato Kosugi
More informationChanges and clinical significance of serum vaspin levels in patients with type 2 diabetes
Changes and clinical significance of serum vaspin levels in patients with type 2 diabetes L. Yang*, S.J. Chen*, G.Y. Yuan, D. Wang and J.J. Chen Department of Endocrinology, Affiliated Hospital of Jiangsu
More informationDiabetes Care 36: , 2013
Cardiovascular and Metabolic Risk O R I G I N A L A R T I C L E Fibroblast Growth Factor 21 Predicts the Metabolic Syndrome and Type 2 Diabetes in Caucasians THOMAS BOBBERT, MD 1 FRANZISKA SCHWARZ 1 ANTJE
More informationRELATIONSHIP OF CLINICAL FACTORS WITH ADIPONECTIN AND LEPTIN IN CHILDREN WITH NEWLY DIAGNOSED TYPE 1 DIABETES. Yuan Gu
RELATIONSHIP OF CLINICAL FACTORS WITH ADIPONECTIN AND LEPTIN IN CHILDREN WITH NEWLY DIAGNOSED TYPE 1 DIABETES by Yuan Gu BE, Nanjing Institute of Technology, China, 2006 ME, University of Shanghai for
More informationAn excessive increase in glutamate contributes to glucose-toxicity in. β-cells via activation of pancreatic NMDA receptors in rodent diabetes
An excessive increase in glutamate contributes to glucose-toxicity in β-cells via activation of pancreatic NMDA receptors in rodent diabetes Xiao-Ting Huang 1, Chen Li 1,3, Xiang-Ping Peng 1, Jia Guo 1,5,
More informationImpact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients
2012 International Conference on Life Science and Engineering IPCBEE vol.45 (2012) (2012) IACSIT Press, Singapore DOI: 10.7763/IPCBEE. 2012. V45. 14 Impact of Physical Activity on Metabolic Change in Type
More informationAssociation between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese
Diabetes Care Publish Ahead of Print, published online June 12, 2008 Raised Blood Pressure and Dysglycemia Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese Bernard My Cheung,
More informationLATENT AUTOIMMUNE DIABETES IN ADULTS (LADA)
ORIGINAL ARTICLES LATENT AUTOIMMUNE DIABETES IN ADULTS (LADA) Alexandra Sima 1, Mihaela Rosu 1, Adrian Vlad 1, Gheorghe Silberberg 2, Viorel Serban 1 ABSTRACT Background: It is difficult to classify diabetes
More informationXia Li, Gan Huang, Jian Lin, Lin Yang and Zhiguang Zhou *
Li et al. BMC Endocrine Disorders 2013, 13:10 RESEARCH ARTICLE Open Access Variation of C peptide decay rate in diabetic patients with positive glutamic acid decarboxylase antibody: better discrimination
More informationElevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with
Elevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with Insulin Resistance Mehrnoosh Shanaki, Ph.D. Assistant Professor of Clinical Biochemistry Shahid Beheshti
More informationComprehensive Screening Detects Undiagnosed Autoimmunity In Adult-onset Type 2 Diabetes
Comprehensive Screening Detects Undiagnosed Autoimmunity In Adult-onset Type 2 Diabetes SRINIVASA R. NAGALLA, MD, PATURI V. RAO, MD, CARYN K. SNYDER, MPH, JERRY P. PALMER, MD, CHARLES T. ROBERTS, PhD DiabetOmics,
More informationHbA1c is associated with intima media thickness in individuals with normal glucose tolerance
Diabetes Care Publish Ahead of Print, published online October 6, 2009 Glucose metabolism and IMT HbA1c is associated with intima media thickness in individuals with normal glucose tolerance Thomas Bobbert,
More informationAssociation of serum adipose triglyceride lipase levels with obesity and diabetes
Association of serum adipose triglyceride lipase levels with obesity and diabetes L. Yang 1 *, S.J. Chen 1 *, G.Y. Yuan 1, L.B. Zhou 2, D. Wang 1, X.Z. Wang 1 and J.J. Chen 1 1 Department of Endocrinology,
More informationFGF21 Resistance in Adipose Tissues as a Cause of Insulin Resistance
Resistance in Adipose Tissues as a Cause of Insulin Resistance The ICDM 213 & 5 th AASD Scientific Meeting Seoul, Korea, Nov 8, 213 Aimin Xu Dept of Medicine & Dept of Pharmacology and Pharmacy The University
More informationLetter to the Editor. Association of TCF7L2 and GCG Gene Variants with Insulin Secretion, Insulin Resistance, and Obesity in New-onset Diabetes *
814 Biomed Environ Sci, 2016; 29(11): 814-817 Letter to the Editor Association of TCF7L2 and GCG Gene Variants with Insulin Secretion, Insulin Resistance, and Obesity in New-onset Diabetes * ZHANG Lu 1,^,
More informationSerum Retinol-binding Protein 4 Levels in Patients with Diabetic Retinopathy
The Journal of International Medical Research 2010; 38: 95 99 Serum Retinol-binding Protein 4 Levels in Patients with Diabetic Retinopathy Z-Z LI 1, X-Z LU 2, J-B LIU 1 AND L CHEN 1 1 Department of Endocrinology,
More information25-Hydroxyvitamin D is closely related with the function of the pancreatic islet β cells
Original Article 25-Hydroxyvitamin D is closely related with the function of the pancreatic islet β cells Jingjing Guo 1, Zhengda Xiao 2, Xia Xue 3, Xin Liu 4, Yong Lu 5, Xiao Yin 6, Kun Ma 7 Open Access
More informationClinical and Laboratory Characteristics of Childhood Diabetes Mellitus: A Single-Center Study from 2000 to 2013
Original Article www.cmj.ac.kr Clinical and Laboratory Characteristics of Childhood Diabetes Mellitus: A Single-Center Study from 2000 to 2013 Tae Hyun Park 1, Min Sun Kim 1,2, * and Dae-Yeol Lee 1,2 1
More information300 Biomed Environ Sci, 2018; 31(4):
300 Biomed Environ Sci, 2018; 31(4): 300-305 Letter to the Editor Combined Influence of Insulin Resistance and Inflammatory Biomarkers on Type 2 Diabetes: A Population-based Prospective Cohort Study of
More information902 Biomed Environ Sci, 2014; 27(11):
902 Biomed Environ Sci, 2014; 27(11): 902-906 Letter to the Editor Curcuminoids Target Decreasing Serum Adipocyte-fatty Acid Binding Protein Levels in Their Glucose-lowering Effect in Patients with Type
More informationLADA prevalence estimation and insulin dependency during follow-up
DIABETES/METABOLISM RESEARCH AND REVIEWS Diabetes Metab Res Rev 2011; 27: 975 979. Published online in Wiley Online Library (wileyonlinelibrary.com).1278 RESEARCH ARTICLE LADA prevalence estimation and
More informationSerum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic
Supplementary Information The title of the manuscript Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke Xin-Wei He 1, Wei-Ling Li 1, Cai Li
More informationDiabetes Care 32: , 2009
Cardiovascular and Metabolic Risk O R I G I N A L A R T I C L E Circulating Fibroblast Growth Factor-21 Is Elevated in Impaired Glucose Tolerance and Type 2 Diabetes and Correlates With Muscle and Hepatic
More informationDiabetes Care Publish Ahead of Print, published online October 17, 2008
Diabetes Care Publish Ahead of Print, published online October 17, 2008 Serum FABPs and diabetic nephropathy Circulating levels of adipocyte and epidermal fatty acid-binding proteins in relation to nephropathy
More informationType 1 Diabetes-Pathophysiology, Diagnosis, and Long-Term Complications. Alejandro J de la Torre Pediatric Endocrinology 10/17/2014
Type 1 Diabetes-Pathophysiology, Diagnosis, and Long-Term Complications Alejandro J de la Torre Pediatric Endocrinology 10/17/2014 Objectives Understand the pathophysiology of Type 1 diabetes. Be familiar
More informationThe relationship between Fibroblast Growth Factor-21 and characteristic parameters related to energy balance in dairy cows
Xu et al. BMC Veterinary Research (2015) 11:271 DOI 10.1186/s12917-015-0585-4 RESEARCH ARTICLE Open Access The relationship between Fibroblast Growth Factor-21 and characteristic parameters related to
More informationOriginal Article Decreased levels of serum fibroblast growth factor 21 in Chinese patients with coronary artery disease
Int J Clin Exp Pathol 2016;9(9):9625-9630 www.ijcep.com /ISSN:1936-2625/IJCEP0035246 Original Article Decreased levels of serum fibroblast growth factor 21 in Chinese patients with coronary artery disease
More informationPrognostic Accuracy of Immunologic and Metabolic Markers for Type 1 Diabetes in a High-Risk Population
Clinical Care/Education/Nutrition/Psychosocial Research O R I G I N A L A R T I C L E Prognostic Accuracy of Immunologic and Metabolic Markers for Type 1 Diabetes in a High-Risk Population Receiver operating
More informationb-cell Autoantibodies and Their Function in Taiwanese Children With Type 1 Diabetes Mellitus
ORIGINAL ARTICLE b-cell Autoantibodies and Their Function in Taiwanese Children With Type 1 Diabetes Mellitus Yi-Ching Tung, 1 Mei-Huei Chen, 2 Cheng-Ting Lee, 1 Wen-Yu Tsai 1 * Background/Purpose: To
More informationDiabetes Care 36: , 2013
Pathophysiology/Complications O R I G I N A L A R T I C L E Serum Fibroblast Growth Factor 19 Levels Are Decreased in Chinese Subjects With Impaired Fasting Glucose and Inversely Associated With Fasting
More informationAssociations among Body Mass Index, Insulin Resistance, and Pancreatic ß-Cell Function in Korean Patients with New- Onset Type 2 Diabetes
ORIGINAL ARTICLE korean j intern med 2012;27:66-71 pissn 1226-3303 eissn 2005-6648 Associations among Body Mass Index, Insulin Resistance, and Pancreatic ß-Cell Function in Korean Patients with New- Onset
More informationPREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS
PREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS Mehmet Emre Atabek,MD,PhD Necmettin Erbakan University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Endocrinology and
More informationDiabetes Day for Primary Care Clinicians Advances in Diabetes Care
Diabetes Day for Primary Care Clinicians Advances in Diabetes Care Elliot Sternthal, MD, FACP, FACE Chair New England AACE Diabetes Day Planning Committee Welcome and Introduction This presentation will:
More informationObesity is a complex disease involving a number of
ORIGINAL Endocrine ARTICLE Research Fibroblast Growth Factor 21 (FGF-21) and Its Relation to Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver in Children: A Longitudinal Analysis Thomas Reinehr,
More informationCorrespondence should be addressed to Emanuela Tsvetkova Zaharieva;
Hindawi Diabetes Research Volume 2017, Article ID 9016148, 6 pages https://doi.org/10.1155/2017/9016148 Research Article Prevalence of Positive Diabetes-Associated Autoantibodies among Type 2 Diabetes
More informationSHORT COMMUNICATION. K. Lukacs & N. Hosszufalusi & E. Dinya & M. Bakacs & L. Madacsy & P. Panczel
Diabetologia (2012) 55:689 693 DOI 10.1007/s00125-011-2378-z SHORT COMMUNICATION The type 2 diabetes-associated variant in TCF7L2 is associated with latent autoimmune diabetes in adult Europeans and the
More informationHigh Glucose Represses b-klotho Expression and Impairs Fibroblast Growth Factor 21 Action in Mouse Pancreatic Islets
ORIGINAL ARTICLE High Glucose Represses b-klotho Expression and Impairs Fibroblast Growth Factor 21 Action in Mouse Pancreatic Islets Involvement of Peroxisome Proliferator Activated Receptor g Signaling
More informationFibroblast Growth Factor 21 (FGF21) in Human Cerebrospinal Fluid. Relationship With Plasma FGF21 and Body Adiposity
BRIEF REPORT Fibroblast Growth Factor 21 (FGF21) in Human Cerebrospinal Fluid Relationship With Plasma FGF21 and Body Adiposity Bee K. Tan, 1,2 Manfred Hallschmid, 3 Raghu Adya, 1 Werner Kern, 4 Hendrik
More informationComparison of the prevalence of islet autoantibodies according to age and disease duration in patients with type 1 diabetes mellitus
Original article http://dx.doi.org/10.6065/apem.2013.18.2.65 Ann Pediatr Endocrinol Metab 2013;18:65-70 Comparison of the prevalence of islet autoantibodies according to age and disease duration in patients
More informationThe fibroblast growth factor (FGF) family is composed
ORIGINAL ARTICLE Serum FGF1 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans Xinmei Zhang, 1, Dennis C.Y. Yeung, 1, Michal Karpisek, 3 David Stejskal,
More information290 Biomed Environ Sci, 2016; 29(4):
290 Biomed Environ Sci, 2016; 29(4): 290-294 Letter to the Editor Prevalence and Predictors of Hypertension in the Labor Force Population in China: Results from a Cross-sectional Survey in Xinjiang Uygur
More informationEvgenija Homšak,M.Ph., M.Sc., EuSpLM. Department for laboratory diagnostics University Clinical Centre Maribor Slovenia
Evgenija Homšak,M.Ph., M.Sc., EuSpLM. Department for laboratory diagnostics University Clinical Centre Maribor Slovenia 14th EFLM Continuing Postgraduate Course in Clinical Chemistry and Laboratory Medicine
More informationAssociation of hypothyroidism with metabolic syndrome - A case- control study
Article ID: ISSN 2046-1690 Association of hypothyroidism with metabolic syndrome - A case- control study Peer review status: No Corresponding Author: Dr. Veena K Karanth, Associate Professor, Surgery,
More informationPrediction and Prevention of Type 1 Diabetes. How far to go?
Prediction and Prevention of Type 1 Diabetes. How far to go? Peter Colman Diabetes and Endocrinology Royal Melbourne Hospital Royal Melbourne Hospital Lancet, Saturday 30 th November 1974; p. 1279-1282
More informationResearch Article Associated Factors with Biochemical Hypoglycemia during an Oral Glucose Tolerance Test in a Chinese Population
Hindawi Diabetes Research Volume 2017, Article ID 3212814, 5 pages https://doi.org/10.1155/2017/3212814 Research Article Associated Factors with Biochemical Hypoglycemia during an Oral Glucose Tolerance
More informationThe investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India
eissn: 09748369, www.biolmedonline.com The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India M Estari, AS Reddy, T Bikshapathi,
More informationCitation for published version (APA): Nilsson, C. (2013). Gestational Diabetes Mellitus- Future risk for mother and child Medicine (Lund)
Gestational Diabetes Mellitus- Future risk for mother and child Nilsson, Charlotta Published: 2013-01-01 Link to publication Citation for published version (APA): Nilsson, C. (2013). Gestational Diabetes
More informationPrevalence of diabetes and impaired fasting glucose in Uygur children of Xinjiang, China
Prevalence of diabetes and impaired fasting glucose in Uygur children of Xinjiang, China J. Zhang 1, Y.T. Ma 1, X. Xie 1, Y.N. Yang 1, F. Liu 2, X.M. Li 1, Z.Y. Fu 1, X. Ma 1, B.D. Chen 2, Y.Y. Zheng 1,
More informationFibroblast Growth Factor 21 and Fetuin-A in Obese Adolescents With and Without Type 2 Diabetes
ORIGINAL ARTICLE Fibroblast Growth Factor 21 and Fetuin-A in Obese Adolescents With and Without Type 2 Diabetes Thomas Reinehr, Beate Karges, Thomas Meissner, Susanna Wiegand, Maria Fritsch, Reinhard W.
More informationJanice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES
Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES Objectives u At conclusion of the lecture the participant will be able to: 1. Differentiate between the classifications of diabetes
More informationPart XI Type 1 Diabetes
Part XI Type 1 Diabetes Introduction Åke Lernmark Epidemiology Type 1 diabetes is increasing worldwide and shows epidemic proportions in several countries or regions [1]. There is evidence to suggest that
More informationSupplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures
Supplementary Data Supplementary Table 1. Baseline Characteristics by Quintiles of Systolic and Diastolic Blood Pressures Quintiles of Systolic Blood Pressure Quintiles of Diastolic Blood Pressure Q1 Q2
More informationAdiponectin, TG/HDL-cholesterol index and hs-crp. Predictors of insulin resistance.
ORIGINAL ARTICLE Adiponectin, TG/HDL-cholesterol index and hs-crp. Predictors of insulin resistance. Bonneau GA y Pedrozo WR 1 Ministry of Public Health, Province of Misiones, 2 School of Exact, Chemical
More informationMetabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk
Metabolic Syndrome Update 21 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes University of Colorado Denver Denver Health Medical Center The Metabolic
More informationSerum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans
Diabetes Publish Ahead of Print, published online February 5, 2008 Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans Xinmei Zhang 1,2 *
More informationShort-Term Insulin Requirements Following Gastric Bypass Surgery in Severely Obese Women with Type 1 Diabetes
Short-Term Insulin Requirements Following Gastric Bypass Surgery in Severely Obese Women with Type 1 Diabetes The Harvard community has made this article openly available. Please share how this access
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery
More informationBariatric Surgery versus Intensive Medical Therapy for Diabetes 3-Year Outcomes
The new england journal of medicine original article Bariatric Surgery versus Intensive Medical for Diabetes 3-Year Outcomes Philip R. Schauer, M.D., Deepak L. Bhatt, M.D., M.P.H., John P. Kirwan, Ph.D.,
More informationA Study on the Presence of Islets Cell Autoantibodies in Non- Insulin Requiring Young Diabetic Patients
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 14, Issue 12 Ver. VI (Dec. 2015), PP 119-123 www.iosrjournals.org A Study on the Presence of Islets Cell
More informationMetabolic Syndrome among Type-2 Diabetic Patients in Benghazi- Libya: A pilot study. Arab Medical University. Benghazi, Libya
Original Article Metabolic Syndrome among Type-2 Diabetic Patients in Benghazi- Libya: A pilot study Alshkri MM 1, Elmehdawi RR 2 1 Benghazi Diabetes Center. 2 Medical Department, Faculty of Medicine,
More informationDiabetes and Cardiovascular Risks in the Polycystic Ovary Syndrome
Diabetes and Cardiovascular Risks in the Polycystic Ovary Syndrome John E. Nestler, M.D. William Branch Porter Professor of Medicine Chair, Department of Internal Medicine Virginia Commonwealth University
More informationStudy of the correlation between growth hormone deficiency and serum leptin, adiponectin, and visfatin levels in adults
Study of the correlation between growth hormone deficiency and serum leptin, adiponectin, and visfatin levels in adults Z.-P. Li 1, M. Zhang 2, J. Gao 3, G.-Y. Zhou 3, S.-Q. Li 1 and Z.-M. An 3 1 Golden
More informationCase 2: A 42 year-old male with a new diagnosis of diabetes mellitus. History - 1
Case 2: A 42 year-old male with a new diagnosis of diabetes mellitus Bruce Knutsen, MD Michael Slag, MD Lisa Thomas, RN, CDE Essentia Health Diabetes and Endocrinology Conference October 14, 2011 History
More information1. PATHOPHYSIOLOGY OF DIABETES MELLITUS
1. PATHOPHYSIOLOGY OF DIABETES MELLITUS Prof. Vladimir Palicka, M.D., Ph.D. Institute for Clinical Biochemistry and Diagnostics, University Hospital Hradec Kralove, Czech Republic Diabetes mellitus is
More informationCardiometabolic Side Effects of Risperidone in Children with Autism
Cardiometabolic Side Effects of Risperidone in Children with Autism Susan J. Boorin, MSN, PMHNP-BC PhD Candidate Yale School of Nursing 1 This speaker has no conflicts of interest to disclose. 2 Boorin
More informationEffective Interventions in the Clinical Setting: Engaging and Empowering Patients. Michael J. Bloch, M.D. Doina Kulick, M.D.
Effective Interventions in the Clinical Setting: Engaging and Empowering Patients Michael J. Bloch, M.D. Doina Kulick, M.D. UNIVERSITY OF NEVADA SCHOOL of MEDICINE Sept. 8, 2011 Reality check: What could
More informationNIH Public Access Author Manuscript Diabetologia. Author manuscript; available in PMC 2014 February 01.
NIH Public Access Author Manuscript Published in final edited form as: Diabetologia. 2013 February ; 56(2): 231 233. doi:10.1007/s00125-012-2788-6. Lipotoxicity impairs incretin signalling V. Poitout 1,2
More informationLiver Enzymes Concentrations Are Closely Related to Pre diabetes: Findings of the Shanghai Diabetes Study II (SHDS II) *
30 Biomed Environ Sci, 2012; 25(1): 30 37 Original Article Liver Enzymes Concentrations Are Closely Related to Pre diabetes: Findings of the Shanghai Diabetes Study II (SHDS II) * GAO Fei 1, PAN Jie Min
More informationSerum uric acid levels improve prediction of incident Type 2 Diabetes in individuals with impaired fasting glucose: The Rancho Bernardo Study
Diabetes Care Publish Ahead of Print, published online June 9, 2009 Serum uric acid and incident DM2 Serum uric acid levels improve prediction of incident Type 2 Diabetes in individuals with impaired fasting
More informationMETABOLIC SYNDROME AND HCV: FROM HCV
METABOLIC SYNDROME AND HCV: FROM THEORY TO PRACTICE HCV Steatosis Insulin resistance Arun J Sanyal M.D. Chairman, Div. of Gastroenterology, Hepatology and Nutrition Virginia Commonwealth University Richmond,
More informationTime dynamics of autoantibodies are coupled to phenotypes and add to the heterogeneity of autoimmune diabetes in adults: the HUNT study, Norway
Diabetologia (2012) 55:1310 1318 DOI 10.1007/s00125-012-2463-y ARTICLE Time dynamics of autoantibodies are coupled to phenotypes and add to the heterogeneity of autoimmune diabetes in adults: the HUNT
More informationATHEROSCLEROTIC cardiovascular complications are the leading cause of. Diabetes Mellitus Has an Additional Effect on Coronary Artery Disease
Diabetes Mellitus Has an Additional Effect on Coronary Artery Disease To Decrease Plasma Adiponectin Levels Kuei-Chuan CHAN, 1 MD, Hsi-Hsien CHOU, 1 PhD, Der-Jinn WU, 1 PhD, Yi-Liang WU, 1 MD, and Chien-Ning
More informationType 1 Diabetes Mellitus in the Adult. Katie Davis & Liz DeJulius KNH 411: Medical Nutrition Therapy I
Type 1 Diabetes Mellitus in the Adult Katie Davis & Liz DeJulius KNH 411: Medical Nutrition Therapy I Diabetes Mellitus: Type I Genetic factor Sudden onset Majority children and adolescents with an increasing
More informationAECOM, Bronx, NY; 2 Incyte Corporation, Wilmington, DE; 3 dgd Research, San Antonio, TX; 4 Profil Institute, San Diego, CA
INCB013739, a Selective Inhibitor of 11β-Hydroxysteroid Dehydrogenase Type 1 (11βHSD1), Improves Insulin Sensitivity and Lowers Plasma Cholesterol Over 28 Days in Patients with Type 2 Diabetes Mellitus
More informationPlasma Concentrations of Fibroblast Growth Factors 21 and 19 in Patients with Cushing's Syndrome
Physiol. Res. 59: 415-422, 2010 Plasma Concentrations of Fibroblast Growth Factors 21 and 19 in Patients with Cushing's Syndrome V. ĎUROVCOVÁ 1, J. MAREK 1, V. HÁNA 1, M. MATOULEK 1, V. ZIKÁN 1, D. HALUZÍKOVÁ
More informationThe Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk
Update 2013 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine Denver Health
More informationGAD65 autoantibodies in women with gestational or insulin dependent diabetes mellitus diagnosed during pregnancy
Diabetologia (1996) 39: 1329 1333 Springer-Verlag 1996 GAD65 autoantibodies in women with gestational or insulin dependent diabetes mellitus diagnosed during pregnancy J.S. Petersen 1, T. Dyrberg 2, P.
More informationAnti-islet autoantibodies in Japanese type 1 diabetes
15 th Korea Japan Symposium on Diabetes Anti-islet autoantibodies in Japanese type 1 diabetes Eiji Kawasaki, Katsumi Eguchi Nagasaki University Hospital, Nagasaki, Japan November 20 21, 21 2009 Cheju Islend
More informationBiomed Environ Sci, 2017; 30(6):
Biomed Environ Sci, 2017; 30(6): 455-459 455 Letter to the Editor Serum Fetuin-A Levels and Thyroid Function in Middle-aged and Elderly Chinese * DENG Xin Ru 1,2,&, DING Lin 1,2,&, WANG Tian Ge 1,2, XU
More informationKenneth, King-yip CHENG (Assistant Professor)
Kenneth, King-yip CHENG (Assistant Professor) QUALIFICATIONS: 2003 2009 BSc (Hons) Biochemistry, Hong Kong University of Science and Technology PhD, Department of Medicine, The University of Hong Kong
More informationJournal of the American College of Cardiology Vol. 48, No. 2, by the American College of Cardiology Foundation ISSN /06/$32.
Journal of the American College of Cardiology Vol. 48, No. 2, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.03.043
More informationThe Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk
The Metabolic Syndrome Update 2018 Marc Cornier, M.D. Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine
More informationDiabetes Care Publish Ahead of Print, published online August 19, 2010
Diabetes Care Publish Ahead of Print, published online August 19, 2010 Neck circumference positively related with central obesity, overweight and metabolic syndrome in Chinese people with type 2 diabetes:
More informationASSOCIATION OF BMI WITH INSULIN RESISTANCE IN TYPE 2 DIABETES MELLITUS -A STUDY IN LOCAL TELANGANA POPULATION
- ISSN: 2321-3272 (Print) IJPBS Volume 5 Issue 4 OCT-DEC 2015 130-136 Research Article Biological Sciences ASSOCIATION OF BMI WITH INSULIN RESISTANCE IN TYPE 2 DIABETES MELLITUS -A STUDY IN LOCAL TELANGANA
More informationDistinguishing T1D vs. T2D in Childhood: a case report for discussion
Distinguishing T1D vs. T2D in Childhood: a case report for discussion Alba Morales, MD Associate Professor of Pediatrics Division of Pediatric Endocrinology and Diabetes Disclosure I have no financial
More informationX/00/$03.00/0 Vol. 85, No. 12 The Journal of Clinical Endocrinology & Metabolism Copyright 2000 by The Endocrine Society
0021-972X/00/$03.00/0 Vol. 85, No. 12 The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright 2000 by The Endocrine Society Prognostic Factors for the Course of Cell Function in
More informationImpacts of combining aerobic exercises with resistance training on chemerin level in obese undergraduates.
Biomedical Research 2017; Special Issue: S654-S658 ISSN 0970-938X www.biomedres.info Impacts of combining aerobic exercises with resistance training on chemerin level in obese undergraduates. Jianyong
More information51 year old woman with hyperglycemia. August 9, 2012 Katie Stanley, MD
51 year old woman with hyperglycemia August 9, 2012 Katie Stanley, MD HPI Diagnosed with DM 1 year prior to visit Established primary care at that time due to notable weight loss after tobacco cessation
More informationHormonal Regulations Of Glucose Metabolism & DM
Hormonal Regulations Of Glucose Metabolism & DM What Hormones Regulate Metabolism? What Hormones Regulate Metabolism? Insulin Glucagon Thyroid hormones Cortisol Epinephrine Most regulation occurs in order
More informationDifference in glucagon-like peptide-1 concentrations between C-peptide negative type 1 diabetes mellitus patients and healthy controls
Original Article Annals of Clinical Biochemistry 2015, Vol. 52(2) 220 225! The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalspermissions.nav DOI: 10.1177/0004563214544709 acb.sagepub.com
More informationLEPTIN AS A NOVEL PREDICTOR OF DEPRESSION IN PATIENTS WITH THE METABOLIC SYNDROME
LEPTIN AS A NOVEL PREDICTOR OF DEPRESSION IN PATIENTS WITH THE METABOLIC SYNDROME Diana A. Chirinos, Ronald Goldberg, Elias Querales-Mago, Miriam Gutt, Judith R. McCalla, Marc Gellman and Neil Schneiderman
More informationHypertriglyceridemia and the Related Factors in Middle-aged Adults in Taiwan
1 Hypertriglyceridemia and the Related Factors in Middle-aged Adults in Taiwan Cheng-Chieh Lin, Tsai-Chung Li 2, Shih-Wei Lai, Kim-Choy Ng 1, Kuo-Che Wang, Chiu-Shong Liu Department of Community Medicine,
More informationUrinary Bisphenol A (BPA) Concentration Associates with Obesity and Insulin Resistance
J Clin Endocrin Metab. First published ahead of print November 16, 2011 as doi:10.1210/jc.2011-1989 JCEM ONLINE Brief Report Endocrine Research Urinary Bisphenol A (BPA) Concentration Associates with Obesity
More informationSignificant gender difference in serum levels of fibroblast growth factor 21 in Danish children and adolescents
Bisgaard et al. International Journal of Pediatric Endocrinology 2014, 2014:7 RESEARCH Open Access Significant gender difference in serum levels of fibroblast growth factor 21 in Danish children and adolescents
More informationPlasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension
World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original
More informationBiochemical markers could predict type-1 diabetes mellitus
Molecular and Biochemical Diagnosis (MBD) Vol 2, No 1, 2016 Original Article Biochemical markers could predict type-1 diabetes mellitus Ragaa H. M. Salama 1*, Yasser F. Abd-Elraheem 2, Khaled H. Mahmoud
More informationDiabetes: Definition Pathophysiology Treatment Goals. By Scott Magee, MD, FACE
Diabetes: Definition Pathophysiology Treatment Goals By Scott Magee, MD, FACE Disclosures No disclosures to report Definition of Diabetes Mellitus Diabetes Mellitus comprises a group of disorders characterized
More informationSupplementary Material 1. Statistical methods used to conduct power calculations.
Supplementary Material 1. Statistical methods used to conduct power calculations. Post-hoc power calculations and patient numbers needed to detect changes were conducted considering (i) the observed partial
More informationTreatment guideline for adult patients with type 1 diabetes?
Treatment guideline for adult patients with type 1 diabetes? Jae Hyeon Kim Division of Endocrinology and Metabolism, Samsung Medical Center, Sungkyunkwan University School of Medicine ICDM 2014 Treatment
More information